These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2461640)

  • 21. The effects of antidepressants on the cerebrospinal fluid homovanillic acid/5-hydroxyindoleacetic acid ratio.
    Risby ED; Hsiao JK; Sunderland T; Agren H; Rudorfer MV; Potter WZ
    Clin Pharmacol Ther; 1987 Nov; 42(5):547-54. PubMed ID: 2445515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purine and monoamine metabolites in cerebrospinal fluid: parallel purinergic and monoaminergic activation in depressive illness?
    Niklasson F; Agren H; Hällgren R
    J Neurol Neurosurg Psychiatry; 1983 Mar; 46(3):255-60. PubMed ID: 6188805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal fluid gamma-aminobutyric acid and homovanillic acid in depressive disorders.
    Kasa K; Otsuki S; Yamamoto M; Sato M; Kuroda H; Ogawa N
    Biol Psychiatry; 1982 Aug; 17(8):877-83. PubMed ID: 7115838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrospinal fluid and plasma monoamines and their metabolites in euthymic bipolar patients.
    Berrettini WH; Nurnberger JI; Scheinin M; Seppala T; Linnoila M; Narrow W; Simmons-Alling S; Gershon ES
    Biol Psychiatry; 1985 Mar; 20(3):257-69. PubMed ID: 2579681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CSF calcium: clinical correlates in affective illness and schizophrenia.
    Jimerson DC; Post RM; Carman JS; van Kammen DP; Wood JH; Goodwin FK; Bunney WE
    Biol Psychiatry; 1979 Feb; 14(1):37-51. PubMed ID: 420907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biogenic amine disturbances in cerebrospinal fluid in parkinsonism and unipolar depression: use of the probenecid method.
    Vanderheyden JE; Noel G; Mendlewicz J
    Neuropsychobiology; 1981; 7(3):137-51. PubMed ID: 6164951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of age, height, and body weight on cerebrospinal fluid amine metabolites and tryptophan in women.
    Banki CM; Molnar G
    Biol Psychiatry; 1981 Aug; 16(8):753-62. PubMed ID: 6169376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Higher CSF levels of HVA and 5-HIAA in delusional compared to nondelusional depression.
    Aberg-Wistedt A; Wistedt B; Bertilsson L
    Arch Gen Psychiatry; 1985 Sep; 42(9):925-6. PubMed ID: 2412522
    [No Abstract]   [Full Text] [Related]  

  • 29. Cerebrospinal fluid correlates of suicide attempts and aggression.
    Brown GL; Goodwin FK
    Ann N Y Acad Sci; 1986; 487():175-88. PubMed ID: 2436532
    [No Abstract]   [Full Text] [Related]  

  • 30. CSF 5HIAA and personal and family history of suicide in affectively ill patients: a negative study.
    Roy-Byrne P; Post RM; Rubinow DR; Linnoila M; Savard R; Davis D
    Psychiatry Res; 1983 Dec; 10(4):263-74. PubMed ID: 6199808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between cerebrospinal fluid amine metabolites, neuroendocrine findings and personality dimensions (Marke-Nyman scale factors) in psychiatric patients.
    Banki CM; Arató M
    Acta Psychiatr Scand; 1983 Apr; 67(4):272-80. PubMed ID: 6190356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CSF cortisol in patients with depression, mania, or anorexia nervosa and in normal subjects.
    Gerner RH; Wilkins JN
    Am J Psychiatry; 1983 Jan; 140(1):92-4. PubMed ID: 6183982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depressive mania versus agitated depression: biogenic amine and hypothalamic-pituitary-adrenocortical function.
    Swann AC; Stokes PE; Secunda SK; Maas JW; Bowden CL; Berman N; Koslow SH
    Biol Psychiatry; 1994 May; 35(10):803-13. PubMed ID: 7519061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: relationship to suicidal behavior and dexamethasone nonsuppression.
    Roy A; Agren H; Pickar D; Linnoila M; Doran AR; Cutler NR; Paul SM
    Am J Psychiatry; 1986 Dec; 143(12):1539-45. PubMed ID: 2431628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consistent evidence for a biological subtype of depression characterized by low CSF monoamine levels.
    Gibbons RD; Davis JM
    Acta Psychiatr Scand; 1986 Jul; 74(1):8-12. PubMed ID: 2429500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Life at risk: markers of suicidality in depression.
    Agren H
    Psychiatr Dev; 1983; 1(1):87-103. PubMed ID: 6201842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism.
    Sher L; Oquendo MA; Li S; Huang YY; Grunebaum MF; Burke AK; Malone KM; Mann JJ
    Neuropsychopharmacology; 2003 Sep; 28(9):1712-9. PubMed ID: 12825091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers.
    De Bellis MD; Geracioti TD; Altemus M; Kling MA
    Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):636-41. PubMed ID: 7687151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study.
    Roy A; De Jong J; Linnoila M
    Arch Gen Psychiatry; 1989 Jul; 46(7):609-12. PubMed ID: 2472124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression.
    Molchan SE; Lawlor BA; Hill JL; Martinez RA; Davis CL; Mellow AM; Rubinow DR; Sunderland T
    Biol Psychiatry; 1991 Jun; 29(11):1110-8. PubMed ID: 1714776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.